This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Parents of kids who have peanut allergies have to practice constant vigilance, whether that means carefully skimming the ingredients on food packaging or warning teachers about the dangers of unexpected treats at school. Europe, Australia, and Canada discuss the results of a Phase 3 trial of the Viaskin Peanut skin patch.
He stressed that for India to continue strengthening its position in global markets, the pharmaceutical industry must ensure that complaints are addressed promptly and efficiently, which, in turn, could prevent public trust from eroding.
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceuticalcompanies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.
In the complex world of pharmaceuticalpackaging, selecting the right blister packaging supplier is a critical decision that can significantly impact product presentation, protection, and compliance. Material Selection Central to the blister packaging process is the selection of appropriate materials.
Additionally, the speed and flexibility needed to thrive in the present competitive environment cannot be provided by traditional techniques of production system installation or reactive manufacturing planning. This challenges us to rethink how products are made, assembled, and packaged.
In India, pharmaceuticalcompanies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Collaborative R&D models and partnerships also present an opportunity for Indian pharma companies to mitigate the risks and costs of innovation.
Manufacturers are actively looking at ways they can improve drug delivery through well-designed parenteral packaging systems, and the choice to deploy prefilled syringes for more and more injectable drug products is a key part of this push. Cost is an important final factor, especially for small and mid-sized pharma companies.
The Janssen PharmaceuticalCompanies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). This new re-brand for the company follows the appointment its new Executive Vice President, Pharmaceuticals, R&D, an ex- Sanofi executive, in February 2023.
This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.
COVID-19 has sped up the digital transformation and forced pharmaceuticalcompanies to rethink many aspects of their business. Sustainability topic, you see that a lot of changes are going on with the packages. Digital transformation “Digital transformation as a whole in the pharma industry has sped up in recent years.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. While using high-capacity aircraft and minimal packaging reduces weight and increases capacity for vital products by using fewer flights.
The call for transparency in the presentation of study sampling methodology should not be limited to RMM effectiveness studies. The sampling strategy must be supported by sound and properly cited sources whose conclusions must be presented as supportive elements in the study documents. Any additional comments?
Documentation : Keeping detailed records of orders, specifications, manufacturing processes, packaging, and labeling to ensure traceability and compliance. Packaging and labeling operations for investigational products are often complex and must meet specific requirements to ensure the integrity of clinical trials.
Accordingly, pharmaceuticalcompanies are expected to up their investment in this area, both in terms of production infrastructure and expertise.”. However, producing generic treatments is significantly different to developing synthesised small-molecule drugs, pushing companies like Chiesi to re-evaluate their role in drug production.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
It means that designs can be carried out in a more templated fashion than at present and presents a change from marketing-as-usual. It might encompass elements such as headlines, body copy, images, calls-to-action, legal copy and logos, and the content can then be used as a framework for messages.
The Viseven team will shine a light on IVAs in pharmacy their role, how to design, adopt, and present them during HCPs’ meetings. These are a key part of e-detailing, which involves using digital platforms for presentations to HCPs. Improved retention How do pharma companies stay top of mind?
211.130 Packaging and labeling operations quotes, – There shall be written procedures designed to ensure that correct labels, labeling, and packaging materials are used for drug products; such written procedures shall be followed. Different products should not be packaged in proximity unless physical segregation exists.
In an era where medicine is rapidly becoming more personalized, why do pharmaceuticalcompanies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceuticalcompanies, creating a unique opportunity to build trust with patients.
Robb : “In pharma the approaches are varied, partly because our clients have any number of customers, including – but not limited to – healthcare practitioners, payers and insurance companies. Clearly, over the last few months, sales reps have had limited in-person access to HCPs, which has presented a challenge. “A
In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. 11 This requirement directly contradicts what is included in Article 63.
It can work more naturally for webinars or bigger, company meetings, but I’ve found it can present issues for smaller groups, where it’s important for everyone to feel involved and be able to contribute equally. “We iii] It’s no longer just about the company, compensation package and secondary benefits (e.g.,
Pharmaceuticalcompanies are looking to paediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. Cambrex, for example, has a track record of success in partnering with several pharmaceuticalcompanies in the development and commercialisation of clinically suitable PDFs. Faster to market.
Our research has demonstrated that these redeveloped inhalers for asthma and COPD, which use carbon-minimal propellant gases, present an effective solution for minimising their carbon emissions 5 and builds on our foundations of transitioning to more environmentally conscious solutions. 5 However, the benefits are well documented.
Pharmaceuticalcompanies are accountable for ensuring that their medicine is safe when it comes into the hands of patients. Many countries have introduced serialisation legislation which requires product identifiers to be affixed to each package to provide traceability throughout the distribution supply chain.
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
It is important to devise a plan as early as possible, starting with an assessment of the overall landscape and the opportunities and challenges presented. While there are some similarities and patterns, the overriding fragmentation of the European market means that a successful access strategy must be country-tailored.
The theme of the event was Innovation, Advanced Technology, Current Challenges & Opportunities in Pharma & Healthcare Industry under which a series of presentation sessions and panel discussions were held related to pharma trends, APIs, policy reforms, AI, metaverse, current regulatory trends and the direction of pharma and drug discovery.
Packaging material specifications In the pharmaceutical industry, the requirements for pre-printed packaging materials must be well-defined and documented to ensure that you get the items you specified or ordered and that there are no mix-ups. A standard name and a unique item code define packaging materials.
Pharmaceuticalcompanies are accountable for properly warehousing, shipping their products, and guaranteeing their stability until expiry. Process validation master plan The process validation master plan accounts for all manufacturing and packaging processes directly employed in the manufacturing and packaging registered products.
While semaglutide presents a promising solution for weight loss, there are risks and downsides to consider. Another question is whether pharmaceuticalcompanies will improve their game by getting approval for an oral version of GLP-1.
Examples include oil leaks from equipment in a packaging line or small solvent spills in the printing and labeling machine. formalin) present a threat due to vapors. – All materials used in the clean-up activities have been packaged for appropriate disposal or have been cleaned and returned. – Some chemicals (e.g.,
Particularly the printed packaging materials where product information is presented. Printed packaging materials typically include product names, active ingredients, concentration, batch numbers, expiry dates, registration numbers, barcodes, etc. Access to exclusive content for an affordable fee.
The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.
You should not be unfamiliar with it if you know how pharmaceutical facilities operate. Cross contamination in pharmaceutical industry is a serious issue which can affect the quality and safety of drugs. What are the examples of cross contamination in pharmaceutical industry? Cross contamination data that can make you nervous!
Stability testing overview for Pharmaceutical products Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST Pharmaceutical products must maintain quality, safety, purity and efficacy throughout their specified shelf-life conditions up to their nominated expiration date.
From patients, patient bodies, pharmaceuticalcompanies, and academia, to regulatory bodies, public institutions, and small and medium-sized enterprises (SMEs), all key stakeholders must come together to help the patients who most need new medicines to access them as quickly as possible. About the author.
Future sustainability efforts must also focus on public education, awareness, and perceptions regarding pharmaceutical pollution. Other strategies can be waste minimisation, green packaging, energy efficiency and sustainable sourcing.
This article will explore the key considerations, best practices, and regulatory requirements for effective cleaning and sanitation that pharmaceuticalcompanies must adhere to for optimal cleanliness and safety. pharmaceutical raw materials, and processing equipment. pharmaceutical raw materials, and processing equipment.
In the 1990s, generic pharmaceuticalcompanies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The European Commission plans to launch its revised EU pharmaceuticalpackage in Q1 2023 to ease drug shortages,” she says.
We are esteemed and elated to present a list of the 20 women who have excelled in reaching the summit of excellence, arranged alphabetically Total experience: 16 yrs. Presentcompany and time period: Pfizer (2 yrs.) Presentcompany and time period: Sensium Healthcare (6 yrs. LinkedIn Total experience: 26 yrs.
There has been an amendment under income tax provisions to disallow such expenses incurred by pharmaceuticalcompanies in violation of MCI regulations. – This will also expand the scope for private health insurance companies to include them in their products, irrespective of the package cost.
This article will explore the key considerations, best practices, and regulatory requirements for effective cleaning and sanitation that pharmaceuticalcompanies must adhere to for optimal cleanliness and safety. pharmaceutical raw materials, and processing equipment. pharmaceutical raw materials, and processing equipment.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content